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Abstract
Background: Only a minority of all alcohol- and drug abusers is receiving professional care. In an
attempt to narrow this treatment gap, treatment facilities experiment with online healthcare.
Therefore, it is important to test the (cost-)effectiveness of online health interventions in a
randomized clinical trial.
Methods: This paper presents the protocol of a three-arm randomized clinical trial to test the
(cost-) effectiveness of online treatment for problem drinkers. Self-help online, therapy online and
a waiting list are tested against each other. Primary outcome is change in alcohol consumption.
Secondary outcome measures include quality of life and working ability. Incremental cost-
effectiveness ratios for self-help online alcohol and therapy online alcohol will be calculated. The
predictive validity of participant characteristics on treatment adherence and outcome will be
explored.
Discussion: To our best knowledge, this randomized clinical trial will be the first to test the
effectiveness of therapy online against both self-help online and a waiting-list. It will provide
evidence on (cost-) effectiveness of online treatment for problem drinkers and investigate outcome
predictors.
Trial registration: This trial is registered in the Dutch Trialregister (Cochrane Collaboration)
and traceable as NTR-TC1155.
Background
The Netherlands have, compared to most other countries,
a fairly accessible network of substance abuse treatment
centres (SATCs). However, the target population of these
SATCs is not sufficiently addressed: Only a minority of all
current alcohol- and drug abusers is receiving professional
care [1]. This so-called treatment gap is mainly due to two
reasons. As substance dependence is strongly stigmatized,
the threshold to visit a treatment centre is high [2]. And as
most SATCs offer outpatient facilities during working
hours only, many people with jobs cannot find to attend
SATCs face-to-face therapy.
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Another challenge to healthcare in general and addiction
treatment in particular is optimising cost-effectiveness. As
the future health spending is expected to increase at a
much higher rate than in the past [3,4], cost-effectiveness
is an important parameter in the development of new
treatment programs. In general, early interventions, pre-
ventive care, and disease self-management, together with
the correct implementation of health information tech-
nology and internet applications, is believed to have the
potential to enhance health status while improving effi-
ciency and reducing healthcare costs [3].
Substance abuse treatment over the internet has the
potential to address these issues: The influence of both
stigmatization and restricted opening times of healthcare
institutions is reduced when clients do not have to visit a
SATC during working hours, but can visit their web-based
treatment environment from any place and at any time.
Earlier evaluations have shown that a majority of online
substance abuse treatment participants manage to hold
their jobs [5,6]. Therefore, improvement in job perform-
ance may be expected as a result of successful participa-
tion, as problematic drinking habits tend to interfere with
working ability in general.
The increasing number of online treatment options
worldwide shows that treatment facilities are willing to
experiment with online healthcare. A review of the current
state of the art in substance abuse treatment over the inter-
net is promising [7]. Some authors report online sub-
stance abuse treatment to be successful in addressing an
underserved population [5,6]. Results of the first rand-
omized clinical trials support the use of the internet to
extend the treatment options for substance abusers [8-10].
There is preliminary evidence on the cost-effectiveness of
early interventions and computer-aided therapy for alco-
hol related problems [11,12]. However, as the number of
randomized clinical trials for online substance abuse
treatment is still sparse, its (cost-)effectiveness is yet to be
supported more firmly. This article presents a randomized
clinical trial that will extend the knowledge on effective-
ness and cost-effectiveness of online treatment for prob-
lem drinkers.
The SATC whose interventions are subjected to this trial
has pioneered in the development of internet applications
for problematic alcohol and substance users. Since 2003,
its online treatment programs have been based on two
evidence-based techniques: cognitive-behavioural therapy
(CBT) and motivational enhancement training. These
early experiences have led to the development of online
interventions for alcohol-, cannabis-, cocaine- and
tobacco-users, and for pathological gamblers. Two online
treatment programs for problem drinkers will be com-
pared in this trial. One is an anonymous, online, non-
counsellor involved, fully automated self-guided treat-
ment program, referred to as Self-help Online Alcohol
(SOA). The other is a real time, online, non anonymous,
counsellor-guided therapy program for problem drinkers
referred to as Therapy Online Alcohol (TOA).
SOA introduces participants to various CBT elements as a
means to monitor and help them change their alcohol
consumption. Registration of alcohol consumption,
online diary, goal setting, and relapse prevention are
among them. A recent study has shown that SOA is highly
attractive and promising in its effects [6]. However, partic-
ipants of SOA did report they missed the opportunity to
interact with a counsellor on a regular basis. In response
to the participants' suggestions, the online therapy pro-
gram (TOA) has been developed. Like SOA, TOA is based
on CBT and motivational enhancement training, but has
a more intensive and stricter structured treatment course
and regular counsellor interaction. Contact between client
and counsellor takes place online in a one-on-one, private
chat-room. TOA resembles to a great extent the conven-
tional face-to-face manual based CBT training program
[13], used in many SATCs in the Netherlands. Treatment
elements of TOA include consumption registration,
online diary, tailored feedback of recent alcohol con-
sumption, contemplating advantages and disadvantages
of drinking, goal setting, self-control methods, investigat-
ing risk-situations, coping with craving, emotions and
social pressure, and the formulation of emergency plans
in case of relapse. These elements are introduced by the
counsellor. Working with the treatment elements is part
of clients' weekly homework assignments.
The most important difference between SOA and TOA are
seven real-time, one-on-one chat sessions with an experi-
enced counsellor trained in TOA. Each chat session lasts
for approximately 40 minutes. During these sessions,
feedback on homework assignments is provided and the
client is motivated to enhance his or her attempt to stop
or reduce drinking. Because of it's interactive nature, chat-
sessions resemble to a big extent the conversational
dynamics of regular, face-to-face therapy contacts. This
new element meets the expressed needs of participants of
SOA and makes the intervention more similar to the suc-
cessful face-to-face CBT treatment.
Methods
Aims of the trial
This study aims to test the effectiveness and cost-effective-
ness of SOA and TOA against a waiting list control group,
in a three-arm randomized clinical trial. Primary outcome
measure is the change in alcohol consumption from base-
line (t0) to the three month follow-up (t1) and to the six
month follow-up (t2). Secondary outcome measures are
changes in AUDIT scores, quality of life and quality of
functioning at work. Incremental cost-effectiveness ratios
for SOA and TOA will be calculated. The predictive valid-BMC Public Health 2009, 9:16 http://www.biomedcentral.com/1471-2458/9/16
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ity of participant characteristics on treatment adherence
and outcome will be explored.
Study population
Our study population will be recruited through the SATCs
website, that was viewed by 650.000 unique visitors in
2007 [14]. If necessary, additional attention for this study
will be attracted through advertisements at family doctors'
offices, internet-forums, and news-paper adds. Applicants
meeting inclusion criteria defined in Table 1 are invited to
participate.
Research questions
Q1a. Do TOA participants reduce their alcohol consump-
tion from t0 to t1 and t2 to a larger extent than SOA and
waiting list control participants?
Q1b. Do TOA participants improve to a larger extent on
secondary outcome measurement scores from t0 to t1 and
t2 than SOA and waiting list control participants?
Q1c. Are TOA participants more often treatment-respond-
ers than SOA and waiting list control participants at t1
and t2?
Q1d. Do SOA participants reduce their alcohol consump-
tion to a larger extent from t0 to t1 and t2 than waiting list
control participants?
Q1e. Do SOA participants improve on secondary out-
come measurement scores from t0 to t1 and t2 to a larger
extent than waiting list control participants?
Q1f. Are SOA participants more often treatment-respond-
ers than waiting list control participants at t1 and t2?
Q2. What are the comparative costs per quality adjusted
life year (QALY) for SOA and TOA?
Q3a. How do participants' demographic characteristics
relate to demographics of participants in conventional
face-to-face CBT programs?
Q3b. Do scores of working alliance between TOA partici-
pants and counsellor predict treatment-response at t1 and
t2?
Hypotheses
We hypothesize TOA participants will have reduced their
alcohol consumption significantly more at the three
month follow-up (t1) compared to SOA and waiting list
control participants (Q1a). Between t0 and t1, we also
expect TOA participants to improve on secondary out-
come measurements (quality of life and working abilities)
significantly more than SOA and waiting list control par-
ticipants (Q1b). We hypothesize that a larger percentage
of TOA participants will meet the criteria for treatment-
responders compared to SOA and waiting list control par-
ticipants (Q1c). We hypothesize that SOA participants
will have reduced their t0 alcohol consumption signifi-
cantly more at t1 than waiting list control participants
(Q1d). Between t0 and t1, we also expect SOA participants
to improve on secondary outcome measurements signifi-
cantly more than waiting list control participants (Q1e).
Finally, we hypothesize that a larger percentage of SOA
participants will meet the criteria for treatment-respond-
ers compared to waiting list control participants (Q1f).
Between t1 and t2, we expect TOA participants to be better
able than SOA participants to maintain their achieved
changes in alcohol consumption, resulting in a significant
time (t1–t2) by group (SOA-TOA) interaction. Alcohol
consumption in SOA will be significantly higher at t2
compared to t1, whereas alcohol consumption in TOA
will not change significantly during this period.
For question 2, we hypothesize that from t0 to t1 both the
costs and the gains in QALY for SOA to be lower than the
Table 1: Selection criteria for inclusion
Inclusion criteria Exclusion criteria
age 18 – 64 prior therapy in addiction treatment centre
internet at home history of alcohol delirium
AUDIT score > 8 history of drug overdose
alcohol consumption > 14 standard units per week severe coronary problems
informed consent received severe intestine diseases
diagnosed schizophrenic
history of stroke
epilepsy in last year
contemplated or attempted suicide in last year
cocaine and or amphetamine use > 4 days last month
cannabis use > 9 days last month
holiday/travelling intention > 2 weeks during trialBMC Public Health 2009, 9:16 http://www.biomedcentral.com/1471-2458/9/16
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costs and the gains in QALY for TOA. As this means that
both the numerator and the denominator of the cost-
effectiveness equation is larger for TOA compared to SOA,
we have no preconceptions of whether the incremental
cost-effectiveness calculation will favour either SOA or
TOA (Q2).
For question 3, we hypothesize our participants to be
higher educated, a larger percentage to be working and
female, compared to conventional outpatient SATC cli-
ents (Q3a). We also hypothesize that higher scores on
working alliance will predict a larger proportion of treat-
ment-response at t1 for TOA participants (Q3b).
Measurement instruments
Several measurement instruments are included in the t0,
t1 and t2 questionnaire, as presented in Table 2. Alcohol
consumption will be measured using substance use sub-
scales of the 'European Addiction Severity Index' (Euro-
pASI) [15] and Timeline-Follow-Back for alcohol
consumption [16]. This Timeline-Follow-Back method
has good capacity to retrieve drinking history in the past
week [17]. As a third scale to measure alcohol consump-
tion burden the AUDIT is included [18].
Quality of life will be measured using two instruments:
The EQ-5D [19-21] and the QOL [22]. The EQ-5D is a
highly accepted, widely used and easy to administer
instrument for measuring quality of life for alcohol and
drug dependents [23,24]. As the scoring algorithm of the
EQ-5D generates an index weighted by a preference meas-
ure, EQ-5D scores can be used in cost-effectiveness analy-
sis to estimate QALYs [25]. However, it is recommended
that the EQ-5D is used in combination with other quality
of life instruments. This should be done to minimize its
potential limitation in sensitivity until further results con-
firm EQ-5D validity in alcohol dependent individuals
[26]. Therefore, the 'Quality Of Life' scale QOL [22] is
included. According to content validity analysis, this is a
valid instrument for measuring quality of life across
patient groups and cultures. It is conceptually distinct
from health status or other causal indicators of quality of
life [27].
As an earlier evaluation study of SOA has shown that a
majority of its participants manage to hold jobs [5,6],
their problematic drinking habit could negatively influ-
ence their working ability. To be able to measure this
effect, we included two working ability measurement
scales. The SF-HLQ, a subscale of the Trimbos/iMTA ques-
tionnaire for Costs associated with Psychiatric Illness
(TiC-P) [28], is well able to measure the work related pro-
ductivity of applicants who held a job in the past two
weeks. A more general measure of working ability, which
is also eks held a job. A more general applicable for the
applicants who are not currently employed, is provided by
the 'Working Ability Index' (WAI-work) [29]. This ques-
tionnaire measures self-reported ability to work, as
opposed to the SF-HLQ which measures the actual work-
ing behaviour.
Key demographical characteristics will be measured using
subscales of the EuropASI [15]. Baseline psychopathology
will be measured using the Brief Symptom Inventory
(BSI) [30,31]. To be able to evaluate the reliability of the
self-reported questionnaire data, a 13-item version of the
Marlowe Crowne Social Desirability Scale (MCSDS) [32]
is included.
Primary and secondary outcome measures
Primary outcome measures are the differences in alcohol
consumption, and the number of participants showing
'treatment response', as defined below. Although de facto
a composite score of primary and secondary outcomes,
'treatment response' is considered primary outcome as
well. Secondary outcome measurements are AUDIT-score;
quality of life as measured by QOL, and EQ-5D, psycho-
pathological symptoms as measured by BSI and ability to
work as measured by SF-HLQ and WAI-work.
Table 2: Measurement instruments
Instrument t0 measure t1 measure t2 measure
EuropASI (subscales) x x x
Timeline-follow-back x x x
AUDIT x x x
QOL x x x
EQ-5D x x x
WAI-work x x x
SF-HLQ x x x
BSI x x x
MCSDS x
Dutch mental health thermometer x* x*
WAI x* x*BMC Public Health 2009, 9:16 http://www.biomedcentral.com/1471-2458/9/16
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Definition of treatment-response
Adding treatment-response criteria has an important
advantage over the comparison of group mean-scores on
primary and secondary outcome measures only. In our
opinion, it has more external validity as it is helpful in
making a clear statement on who actually improved to a
clinical relevant extent. Based on binary treatment-
response outcome data, we can calculate relative risk
reduction, number needed to treat, and odds ratios. The
British Medical Association published guidelines on sen-
sible drinking which suggested that the boundaries for
sensible alcohol consumption should be set at a maxi-
mum of 21 standard alcohol units per week for men, and
14 standard alcohol units per week for women [33]. To
calculate treatment-response outcome, alcohol consump-
tion as measured using Timeline-Follow-Back will be used
[16]. Deteriation percentages relate to changes within par-
ticipants on the secondary outcome measurement scores
between t0 and t1. Treatment-response is defined as: 'alco-
hol consumption within British Medical Association bounda-
ries, and less than 10% deteriation on any of the secondary
outcome measures'.
Power calculation
Appropriate sample size is estimated using Gpower
v.3.0.5 software [34]. This calculation is based on the pri-
mary outcome measure (alcohol consumption), in a one-
way ANOVA test design. Based on [10] we expect an effect-
size of d = 0.40 when comparing waiting list control and
treatment groups. To be able to detect even smaller differ-
ential effects (d = 0.25) between SOA en TOA with   = .05
and  = .20, we aim to include 150 participants. The power
calculation is summarized in Table 3.
Randomization
After the t0 measurement is completed, participants are
allocated to one of the three trial arms. Because this rand-
omized clinical trial is internet-based, we will organize the
allocation procedures online as well. As the number of
participants we aim to include in each trial arm (n = 50) is
not very large, random variation in baseline characteristics
could reduce group equivalence. Online, server-based per-
formance of randomization procedures comes with the
advantage of being able to implement stratified allocation
or allocation through adaptive randomization relatively
easy.
To prevent between-group variability on relevant baseline
characteristics, we use an adaptive or biased-coin rand-
omization algorithm for this trial. Adaptive randomiza-
tion aims to ensure trial arms are balanced with respect to
a priori defined participant factors as well as for the
number of participants in each group. Simulation studies
show that adaptive randomization provides better bal-
anced trial arms when compared with 'normal' randomi-
zation [35] and that it is more efficient in balancing
multiple poli-level factors than permutated block stratifi-
cation [36]. Although not widely used due to organiza-
tional complexity, adaptive randomization is a highly
effective allocation method, and its wider adaptation in
the conduct of randomized clinical trials is recommended
[37]. The use of adaptive randomization is supported in
the CONSORT statement [38]. We will implement the
Pocock & Simon Range Method of adaptive randomiza-
tion [39], with D = 'range', G is the sum of D (no factor
weighting), and P = 0.60.
Procedures
For the purpose of this trial we will develop a website to
inform potential applicants about the contents of the
online treatment, and the procedures associated with this
trial. Upon visiting the website, new participants can read
all relevant information and ask additional questions
through a mail form. For included participants, a secured
login system to enter the online interventions is devel-
oped and available on the website. Visitors willing to par-
ticipate fill out a web-based questionnaire to check if they
meet the inclusion criteria. If they do not, they are
informed so, and an email is sent to this applicant. This
email contains additional information about alternative
treatment options. Applicants meeting inclusion criteria
proceed to the subscription screen. Next, they are once
again informed on the conditions of participation in this
trial. After reading all information, they decide whether
they are willing to participate. If they would like to partic-
ipate, they are asked for necessary personal information.
A confirmation email is sent to them, with the informed
consent as an attachment. This confirmation email also
contains their personal username and password. With this
unique username/password combination, applicants can
log in to their private area. Upon logging in for the first
time, applicants are shown a screen which requests them
to confirm they read, understood and agreed with the
informed consent sent to them. Applicants can decide to
agree with this informed consent at any time, and can
deliberate on whether or not they consent with the partic-
Table 3: Power analysis
F tests – ANOVA: Fixed effects, omnibus, one-way
Analysis: A priori: Compute required sample size
Input: Effect size f 0.25
α error probability 0.05
Power (1-β error probability) 0.80
Number of groups 3
Output: Non-centrality parameter λ 9.938
Critical F 3.054
Numerator df 2
Denominator df 156
Total sample size 159
Actual power 0.805BMC Public Health 2009, 9:16 http://www.biomedcentral.com/1471-2458/9/16
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ipant information for as long as they want. Only after
their confirmation they are introduced to the baseline
measurement procedure. After completion of the baseline
measurement the randomization procedure takes place.
Depending on the outcome, participants are allocated to
one of three trial arms.
Trial flow
Figure 1 provides an overview of the trial flow. If a partic-
ipant is allocated to trial arm 1, he or she is directly intro-
duced to TOA through a welcome text. A notification will
now be sent to the TOA coordinator to make a first
appointment for a chat session with the participant. From
now on, TOA starts for participants in trial arm 1. Three
months after t0 measurement, participants will receive an
invitation for the t1 measurement by email and upon vis-
iting the trial website. It is possible that some participants
have not yet finished the entire TOA process after this
period. However, the decision has been made to let fol-
low-up timing depend solely on the time interval since t0,
not on the current status of their treatment proceedings.
This is in our opinion the best possible confirmation to
the 'intention to treat' principle [40]. Three months after
the t1 measurement participants are invited for the t2
measurement. After completion of t2 measurements, data
collection is completed. Participants in trial arm 2 are
introduced to SOA after randomization. Up until t1, par-
ticipants can use the SOA program every time they log in
on the trial website. t1 and t2 measurements are intro-
duced by email and upon visiting the trial website. Partic-
ipants in this trial arm are offered the possibility to
proceed with TOA after completion of t2 measurements,
would they be interested in more help after completion of
SOA. Participants in trial arm 3 are allocated to the wait-
Trial flowchart Figure 1
Trial flowchart. This figure provides an overview of the participant flow for this trial.
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ing list after randomization. After three months, they too
will receive an invitation for the t1 measurement. After t1,
participants in trial arm 3 are introduced to TOA. For eth-
ical reasons, the decision is made to offer them TOA after
three months (t1), and not after t2 (six months).
Maximize response rates
Drop-out is a potential threat in every clinical trial. Since
attrition rates for online trials tend to be larger than in reg-
ular ones [52], we will make extra efforts to maximize
response rates. Following suggestions for successful strat-
egies to maximize response rates [41,42], we made follow-
up questionnaires as short as possible and give partici-
pants feedback on the actual length and their proceedings
while filling out the questionnaire. We motivate partici-
pants to fill out the questionnaires by sending them a
reminder if they do not respond within five days after the
first emailed invitation. To optimize a feeling of worthi-
ness and to reward participants for their efforts and time,
participants will receive gift coupons (€15,-) after filling
out a follow-up questionnaire. Participants will be aware
of this incentive upon reading the informed consent form.
However, participants who do not fill out the question-
naires after a reminder is sent will be contacted by a call
centre. Since 2005, this call centre has been collecting reg-
ular outcome data of outpatient addiction treatment for
SATCs nationwide in the Netherlands. It is experienced in
maximizing response rates in hard to reach populations
[43]. For this research project, they will collect outcome
data by phone from trial participants who do not respond
to emailed invitations. All participants are aware of these
procedures, provide phone numbers, and consent with
receiving phone-calls for follow-up measurements.
Data analysis
Multiple imputation missing data handling procedures
will be implemented using MICE [45] a package for the R
Statistical Software Environment. As the quantity of con-
sumed alcoholic drinks is the primary outcome variable in
this trial, analysis techniques are chosen that suit the
expected data distribution. Baseline measurements of the
three trial arms will be compared using t-tests and χ2-tests.
Trial arm differences on primary and secondary outcome
variables at three months are tested using repeated meas-
ures ANOVA. Trial arm differences for SOA and TOA
between t1 and t2 are tested with a 2 (group) × 2 (time)
repeated measures ANCOVA with between and within
contrasts. Effect-sizes will be calculated using Cohen's d
[46]. Trial arm differences on treatment-response will be
tested using multiple logistic regression analysis. Costs
from TOA and SOA will be derived from cost records of
the collaborating SATC. Costs will be assessed in corre-
spondence to the recommendations by the U.S. Panel on
Cost-effectiveness in Health and Medicine [25], following
a macro-costing approach. QALYs will be calculated from
the EQ-5D questionnaire, using algorithm by Dolan [47],
retrieved from the Open Health Measures website [48].
Based on these estimations, costs-per-QALY and an incre-
mental cost-effectiveness ratio can be calculated. The U.S.
Panel on Cost-effectiveness has recommended that cost-
effectiveness studies should conduct sensitivity analysis,
which for this cost-effectiveness analysis will be imple-
mented through the bootstrap method [49-51].
Ethical approval
This trial will be executed in compliance to the Helsinki
Declaration and is approved by the Medical Ethical Com-
mission of the Academic Medical Center in Amsterdam,
the Netherlands.
Discussion
To our best knowledge, this randomized clinical trial is
the first to test the effectiveness of online therapy (TOA)
against both a derived self-help program (SOA) and a
waiting-list control group. Both SOA and TOA are based
on an evidence-based CBT face-to-face treatment pro-
gramme [13], implemented by several SATCs in the Neth-
erlands. The counsellors involved in TOA are all working
for a well respected, research minded SATC with many
years of experience in the counselling of problem drink-
ers. The AIAR (Amsterdam Institute for Addiction
Research) group has over 15 years of experience in both
clinical and experimental addiction research. This solid
foundation makes a sound opportunity to design and exe-
cute a randomized clinical trial to test effectiveness, while
on the other hand extending knowledge on how internet
technology can be used in healthcare research.
A potential threat for this trial is the so-called 'law of attri-
tion', defined by Eysenbach: 'the phenomenon of partici-
pants stopping usage and/or being lost to follow-up, as
one of the fundamental characteristics and methodologi-
cal challenges in the evaluation of eHealth applications'
[52]. We intent to implement four measures to reduce the
impact of this attrition law. First, data-collection over the
telephone, performed by an experienced call centre as a
backup method for the follow-up measurements gives us
a greater possibility to actively pursuit higher response
rates. Second, all participants in this trial have to make a
major time investment before being randomized and
included in this trial – by filling out a 45 minutes baseline
measurement. As an extra incentive for participation to
the follow-up measurements, all participants receive gift
coupons for their filled-out questionnaires. As a last
resolve, all missing data values in the final data set will be
multiple imputed according to methodology suggested by
Schafer and Graham (2002) [44].
A second potential risk in this trial would concern the
inclusion of participants. The inclusion of enough partic-BMC Public Health 2009, 9:16 http://www.biomedcentral.com/1471-2458/9/16
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ipants is not our main sorrow. As SOA in the regular con-
text and without promotional efforts is able to attract over
150 new participants each month [6], we think we will
manage to include 150 participants in a one year inclu-
sion period. However, the resemblance of the regular
online clientele is our main focus of attention. Due to the
high accessibility of online help in the normal context and
the relatively high constraints posed on participants in
this trial, there is a potential risk that the trial participants
do not resemble the regular e-clientele exactly. Whether
this actually occurs or not can only be answered after-
wards, by comparing data on characteristics of trial partic-
ipants and regular online clientele data.
A third possible limitation concerns integrity of our col-
lected data. As our t0 and t1/t2 data is self reported with-
out a researcher nearby to oversee data-collection, we rely
heavily on the correctness of our participants' answers.
Various authors evaluate the self-reported data in alcohol
research as reliable [53-55]. Tourangeau and colleagues
even concluded that self-reported data is more reliable in
the absence of a research confederate [56]. However, as an
extra means to check data integrity, we included a social
desirability scale, to measure whether these tendencies
occur in our research population.
Another point of concern on data integrity in this trial
could be made about our suggested statistical procedures.
Multivariate statistics relies considerably on data distribu-
tion normality [57]. As the distribution of alcohol con-
sumption count data is usually zero-elevated and highly
skewed, particularly in subjects with alcohol dependence
[58], multivariate statistics and most statistical tests
should be used with caution. To prevent possible in- or
deflated α's, we will use bootstrap methods and permuta-
tion tests as suggested by Hesterberg and colleagues [59],
to minimize the influence of data distributions on our
testing results, if data turn out to be non-normally distrib-
uted.
During the planning stage of this trial we have thought of
implementing a conventional face-to-face treatment com-
parison condition as well. However, it is disputable
whether in clinical practice, the face-to-face treatment and
the online treatment populations are comparable. In pre-
vious pilot studies, we found that less than 10% of the
internet treatment population was willing to receive con-
ventional treatment [6]. On the other hand, all face-to-
face participants who consider themselves as computer-
illiterate, or do not have a computer with internet connec-
tion at home, would be unsuitable for online treatment.
These considerations illustrate not only the methodologi-
cal difficulties of a hybrid online – face-to-face trial, but
also the restricted external validity of it's results. This was
for us the main reason not to chose for a conventional –
internet therapy comparison.
Trial registration
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